OrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Rating of "Moderate Buy" by Brokerages

Key Points

• OrthoPediatrics Corp. (NASDAQ:KIDS) received an average consensus rating of "Moderate Buy" from eight brokerages, with seven issuing buy ratings and one hold rating.
• The company's shares recently opened at $19.19 and have a market cap of $481.17 million, with a fifty-two week price range between $16.59 and $33.14.
• In its latest quarterly earnings report, OrthoPediatrics reported ($0.11) earnings per share, surpassing the expected (0.17) EPS loss, but revenue fell short of expectations at $61.08 million.

Shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eight ratings firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $34.1429.

KIDS has been the subject of several research analyst reports. Citigroup reiterated a "market outperform" rating on shares of OrthoPediatrics in a research report on Friday, August 8th. Piper Sandler decreased their target price on OrthoPediatrics from $40.00 to $30.00 and set an "overweight" rating for the company in a research report on Thursday, May 8th. BTIG Research decreased their target price on OrthoPediatrics from $40.00 to $39.00 and set a "buy" rating for the company in a research report on Wednesday, August 6th. Needham & Company LLC reiterated a "buy" rating and set a $42.00 target price on shares of OrthoPediatrics in a research report on Thursday, May 8th. Finally, Wall Street Zen upgraded OrthoPediatrics from a "sell" rating to a "hold" rating in a research report on Saturday, August 9th.

OrthoPediatrics Trading Up 1.8%

NASDAQ KIDS traded up $0.35 on Friday, hitting $19.48. 175,884 shares of the stock were exchanged, compared to its average volume of 189,616. The company has a debt-to-equity ratio of 0.27, a quick ratio of 3.43 and a current ratio of 6.66. The stock has a fifty day moving average price of $21.11 and a two-hundred day moving average price of $22.30. The firm has a market capitalization of $488.36 million, a P/E ratio of -10.88 and a beta of 1.12. OrthoPediatrics has a 52-week low of $16.59 and a 52-week high of $33.14.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, topping the consensus estimate of ($0.17) by $0.06. The company had revenue of $61.08 million during the quarter, compared to analyst estimates of $61.40 million. OrthoPediatrics had a negative net margin of 18.92% and a negative return on equity of 6.36%. OrthoPediatrics has set its FY 2025 guidance at EPS. Research analysts forecast that OrthoPediatrics will post -0.93 EPS for the current fiscal year.

Institutional Trading of OrthoPediatrics

Several institutional investors and hedge funds have recently made changes to their positions in KIDS. Birchview Capital LP raised its holdings in OrthoPediatrics by 30.0% in the second quarter. Birchview Capital LP now owns 26,000 shares of the company's stock worth $558,000 after purchasing an additional 6,000 shares in the last quarter. Sei Investments Co. boosted its position in shares of OrthoPediatrics by 27.1% in the 2nd quarter. Sei Investments Co. now owns 38,947 shares of the company's stock worth $837,000 after purchasing an additional 8,312 shares in the last quarter. Marshall Wace LLP boosted its position in shares of OrthoPediatrics by 17.8% in the 2nd quarter. Marshall Wace LLP now owns 419,129 shares of the company's stock worth $9,003,000 after purchasing an additional 63,345 shares in the last quarter. Invesco Ltd. boosted its position in shares of OrthoPediatrics by 22.5% in the 2nd quarter. Invesco Ltd. now owns 22,482 shares of the company's stock worth $483,000 after purchasing an additional 4,133 shares in the last quarter. Finally, Grandeur Peak Global Advisors LLC acquired a new stake in shares of OrthoPediatrics in the 2nd quarter worth $452,000. 69.05% of the stock is currently owned by institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.